Recent Progress of Adenosine Receptor Modulators in the Development of Anticancer Chemotherapeutic Agents

Area of Science:

• Oncology
• Immunology
• Pharmacology

Background:

• Chemotherapeutic agents often cause significant peripheral toxicity and adverse effects, diminishing cancer patients' quality of life.
• Current target-specific anticancer drugs show limited efficacy in managing metastatic tumors, necessitating the search for novel therapeutic strategies.
• Adenosine receptors are implicated in antitumor processes, particularly through immune response modulation, presenting a promising target for cancer therapy.

Purpose of the Study:

• To review the biological mechanisms of adenosine receptors in selective cancer cell killing.
• To explore the development of adenosine receptor modulators for cancer treatment.
• To highlight the potential of adenosine receptor-mediated immunomodulation in managing solid tumors.

Main Methods:

• Literature review of studies on adenosine receptors and cancer.
• Analysis of biological mechanisms underlying adenosine receptor's role in antitumor immunity.
• Survey of identified adenosine receptor modulators and their efficacy in preclinical and clinical settings.

Main Results:

• Adenosine receptors play a crucial role in mediating antitumor immune responses.
• Modulation of adenosine receptors can lead to selective cancer cell cytotoxicity.
• Various classes of adenosine receptor modulators have been investigated for solid tumor management.

Conclusions:

• Adenosine receptor-mediated immunomodulation represents a promising frontier in anticancer drug discovery.
• Targeting adenosine receptors offers a strategy to develop safer and more effective chemotherapeutic agents.
• Further research into adenosine receptor modulators could significantly improve the treatment of metastatic and solid tumors.